Impact of <i>CYP1A</i> , <i>CYP2C19</i> , <i>CYP2D6</i> , <i>CYP3A4</i> , <i>CYP3A5</i> , and <i>NFIB</i> genotypes on clozapine serum concentration in smokers and nonsmokers
The <i>CYP1A T</i>, <i>NFIB C</i>, and <i>CYP3A5*1</i> alleles have significant impact on clozapine serum levels. Incorporating genotype information for these variants, together with patient smoking status, would improve algorithms for precision dosing of clozapine.
Authors
- Olav B. Smeland (ORCID: https://orcid.org/0000-0002-3761-5215)
- Espen Molden (ORCID: https://orcid.org/0000-0001-6190-2751)
- Line Skute Bråten (ORCID: https://orcid.org/0000-0001-6887-1986)
- Hasan Çağın Lenk (ORCID: https://orcid.org/0000-0003-4724-7396)
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Diakonhjemmet Hospital (NO)
Publication Details
- Journal
- Therapeutic Advances in Psychopharmacology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/20451253251377183
- Citations
- 1
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.56